Macrophage priming and lipopolysaccharidetriggered release of tumor necrosis factor α during graft-versus-host disease

Journal of Experimental Medicine

Volumn 175, Issue 2, 1992, Pages 405-413

  Nestel, Frederick P ^a   Price, Kursteen S ^a   Seemayer, Thomas A ^b   Lapp, Wayne S ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; GAMMA INTERFERON; INTERFERON ANTIBODY; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW SUPPRESSION; GRAFT VERSUS HOST REACTION; INTESTINE INJURY; MACROPHAGE ACTIVATION; MALE; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMAL; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; GRAFT VS HOST DISEASE; IMMUNE TOLERANCE; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LYMPH NODES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; RABBITS; SPLEEN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR;

EID: 0026573134     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.175.2.405     Document Type: Article

References (64)

1. Howard, J.G., and M.F.A. Woodruff. 1961. Effect of graft-versus-host reaction on the immunological response of the mouse. Proc R. Soc Lond. B. Biol. Sci. 154:532.
2. Blaese, R.M., C. Martinez, and R.A. Good. 1964. Immunologic incompetence of immunologically runted animals. J. Exp Med. 119:211.
3. Lapp, W.S., and G. Môller. 1969. Prolonged survival of H-2 incompatible skin allografts in FI animals treated with parental lymphoid cells. Immunology. 17:339.
4. Gorer, P.A., and E.A. Boyse. 1959. Pathological changes in FI hybrid mice following transplantation of spleen cells from donors of the parental strains. Immunology. 2:182.
5. Seemayer, T.A., W.S. Lapp, and R.P. Bolande. 1977. Thymic involution in murine graft-versus-host reaction: Epithelial injury mimicking human thymic dysplasia. Am.J. Pathol. 88:119.
6. Billingham, R.E., and L. Brent. 1957. A simple method for inducing tolerance of skin homografts in mice. Tmnsplant. Bull. 4:67.
7. Lapp, W.S., T. Ghayur, M. Mendes, M. Seddick, and T.A. Seemayer. 1985. The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol. Reu 88:107.
8. Howard, J.G. 1961. Changes in the activity of the reticuloendothelial system (RES) following the injection of parental spleen cells into FI hybrid mice. Br. J. Exp Pathol. 42:72.
9. Cooper, G.N., and J.G. Howard. 1961. An effect of the graft-versus-host reaction on resistance to experimental bacteraemia. Br. J. Exp Pathol. 42:588.
10. Pace, J.L., and S.W. Russell. 1981. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. J. Immunol. 126:1863.
11. Pace, J.L., S.W. Russell, B.A. Torres, H.M. Johnson, and P.W. Gray. 1983. Recombinant mouse 7 interferon induces the priming step in macrophage activation for tumor cell killing. J. Immunol. 130:2011.
12. Gifford, G.E., and M.-L. Lohmann-Matthes. 1987. Gamma interferon priming of mouse and human macrophages for induction of tumor necrosis factor production by bacterial lipopolysaccharide. J. Natl. Cancer Inst. (Bethesda). 78:121.
13. Niederwieser, D., M. Herold, W. Woloszczuk, W. Aulitzky, B. Meister, H. Tilg, G. Gastl, R. Bowden, and C. Huber. 1990. Endogenous IFN-gamma during human bone marrow transplantation: Analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation (Baltimore). 50: 620.
14. Velardi, A., P. Varese, A. Terenzi, C. Dembech, N. Albi, C.E. Grossi, L. Moretta, M.F. Martelli, F. Grignani, and M.C. Min-gari. 1989. Lymphokine production by T-cell clones after human bone marrow transplantation. Blood. 74:1665.
15. Klimpel, G.R., C.R. Annable, M.G. Cleveland, T.R. Jerrells, and J.C. Patterson. 1990. Immunosuppression and lymphoid hypoplasia associated with chronic graft-versus-host disease is dependent upon IFN-7 production. J. Immunol. 144:84.
16. Mowat, A.M. 1989. Antibodies to IFN-7 prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology. 68:18.
17. Howard, J.G. 1961. Increased sensitivity to bacterial endotoxin of FI hybrid mice undergoing graft-versus-host reaction. Nature (Lond.). 190:1122.
18. Nestel, F.P., T.A. Seemayer, and W.S. Lapp. 1988. Cachectin production during murine graft-versus-host reactions. FASEB (Fed. Am. Soc. Exp Biol.) J. 2:A448. (Abstr.)
19. Van Bekkum, D.W., J. Roodenburg, P.J. Heidt, and D. van der Waaij. 1974. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J. Natl. Cancer Inst. 52:401.
20. Jones, J.W., R. Wilson, and P.M. Bealmear. 1971. Mortality and gross pathology of secondary disease in germffee mouse radiation chimeras. Radiat. Res. 45:577.
21. Prentice, R.L., D.C. Buckner, R.A. Clift, F. Applebaum, J. Deeg, K. Doney, J.A. Hansen, M. Mason, J.E. Sanders, J. Singer, K.M. Sullivan, R.P. Witherspoon, and E.D. Thomas. 1983. Graft-versus-host disease and survival in patients with aplastic anaemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N. Engl. J. Med. 308:302.
22. Mannei, D.N., R.N. Moore, and S.E. Mergenhagen. 1980. Macrophages as a source of tumoricidal activity (Tumor Necrotizing Factor). Infect. Immun. 30:523.
23. Torti, F.M., B. Dieckmann, B. Beutler, A. Cerami, and G.M. Ringold. 1985. A macrophage product inhibits adipocyte gene expression: an in vitro model of cachexia. Science (Wash. DC). 229:867.
24. Beutler, B., J. Mahoney, N. Le Trang, P. Fekala, and A. Cerami. 1985. Purification of cachectin A lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells. J. Exp Med. 161:984.
25. Beulter, B.A., I.W. Milsark, and A.C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (Wish. DC). 229:869.
26. Sugarman, B.J., B.B. Aggarwal, P.E. Hass, I.S. Figari, M.A. Palladino, and H.M. Shepard. 1985. Recombinant human tumor necrosis factor-a: Effects on proliferation of normal and transformed cells in vitro. Science (Wish. DC). 230:943.
27. Tracey, K.J., H. Wei, K.R. Manogue, Y. Fong, D.G. Hesse, H.T. Nguyen, G.C. Kuo, B. Beutler, R.S. Cotran, A. Cerami, and S.F. Lowry. 1988. Cachectin/tumor necrosis factor induces cachexia, anaemia, and inflammation. J. Exp Med. 167:1211.
28. 1 (endotoxin resistance) phenotype. J. Exp Med. 164:1791.
29. Piguet, P.-F., G.E. Grau, B. Allet, and P. Vassalli. 1987. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J. Exp Med. 166:1280.
30. Hirokawa, M., H. Takatsu, H. Niitsu, T. Nishinari, T. Nimura, T. Itoh, A. Chubachi, I. Miura, K. Yoshida, Y. Endo, and A. Miura. 1989. Serum tumor necrosis factor-a levels in allogeneic bone marrow transplant recipients with acute leukemia. To-hoku f. Exp. Med. 159:237.
31. Holler, E., H. Kolb, A. Möller, J. Kempeni, S. Liesenfeld, H. Pechumer, W. Lehmacher, G. Ruckdeschel, B. Gleixner, C. Riedner et al. 1990. Increased serum levels of tumor necrosis factor a precede major complications of bone marrow transplantation. Blood. 75:1011.
32. Symington, F.W., M.S. Pepe, A.B. Chen, and A. Deliganis. 1990. Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. Transplantation (Baltimore). 50:518.
33. Cunningham, A.J., and A. Szenberg. 1968. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology. 14:599.
34. Parthenais, E., and W.S. Lapp. 1978. Evidence for two types of nonspecific suppressor cells activated by the graft-versus-host reaction in mice. Scand. J. Immunol. 7:215.
35. McGarritty, G.J., and D.A. Carson. 1982. Adenosine phos-phorylase-mediated nucleoside toxicity: Application towards the detection of mycoplasma infection in mammalian cell cultures. Exp Cell Res. 139:199.
36. Nestel, F.P., P.R. Casson, R.H. Wiltrout, and R.S. Kerbel. 1984. Alterations in sensitivity to nonspecific cell-mediated lysis associated with tumor progression: Characterization of activated macrophage and natural killer cell resistant tumor variants. J. Natl. Cancer Inst. 73:483.
37. Flick, D.A., and Gifford, G.E. 1984. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods. 68:167.
38. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:55.
39. Munford, R.S., C.L. Hall, J.M. Lipton, and J.M. Dietschy. 1982. Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. J. Clin. Invest. 70:877.
40. Schumann, R.R., S.R. Leong, G.W. Flaggs, P.W. Gray, S.D. Wright, J.C. Mathison, P.S. Tobias, and R.J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science (Wash. DC). 249:1429.
41. Reyes, V.E., and G.R. Klimpel. 1987. Interferon α/β synthesis during acute graft-versus-host disease. Transplantation (Baltimore). 43:412.
42. Pace, J.L., S.W. Russell, P.A. Leblanc, and D.M. Murasko. 1985. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing. J. Immunol. 134:977.
43. Cerami, A., Y. Ikeda, N. Le Trang, P.J. Hotez, and B. Beutler. 1985. Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: The role of cachectin (tumor necrosis factor). Immunol. Lett. 11:173.
44. Beutler, B.A., I.W. Milsark, and A. Cerami. 1985. Cachectin/ Tumor necrosis factor: Production, distribution and metabolic fate in vivo. J. Immunol. 135:3972.
45. Sherry, B.A., J. Gelin, Y. Fong, M. Marano, H. Wei, A. Cerami, S.F. Lowry, K.G. Lundholm, and L.L. Moldawer. 1989. An-ticachectin/tumor necrosis-a antibodies attenuate development of cachexia in tumor models. FASEB (Fed. Am. Soc Exp Biol.) J. 3:1956.
46. Owens, W.E., and R.D. Berg. 1980. Bacterial translocation from the gastrointestinal tract of a thymic (nu/nu) mice. Infect. Immun. 27:461.
47. Hampton, R.Y., D.T. Golenbook, M. Penman, M. Kreiger, and C.R.H. Raetz. 1991. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature (Lond.). 352:342.
48. Elie, R., and W.S. Lapp. 1977. Graft-versus-host induced immunosuppression: Mechanism of depressed T-cell helper function in vitro. Cell. Immunol. 34:38.
49. Cuturi, M.C., M. Murphy, M.P. Costa-Giomi, R. Weinmann, B. Perussia, and G. Trinchieri. 1987. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp Med. 165:1581.
50. Peters, P.M., J.R. Ortaldo, M.R. Shalaby, L.P. Svedersky, G.E. Nedwin, T.S. Bringman, P.E. Hass, B.B. Aggarwal, R.B. Her-berman, D.V. Goeddel, and M.A. Palladino. 1986. Natural killer sensitive targets stimulate production of TNF-a but not TNF-β (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J. Immunol. 137:2592.
51. Gordon, J.R., and S.J. Galli. 1990. Mast cells as a source of both preformed and immunologically inducible TNF-α cachectin. Nature (Lond.). 346:274.
52. Papadimitriou, J.M., and D. Keast. 1969. The electron microscopy of livers of mice runted as a result of the graft versus host reaction and bacterial endotoxin. Br. J. Exp Path. 50:574.
53. Van Bekkum, D.W., and S. Knaan. 1977. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J. Natl. Cancer Inst. (Bethesda). 58:787.
54. Moore, R.H., I.A. Lampert, Y. Chia, V.R. Aber, andj. Cohen. 1987. Effect of immunization with Escherichia coli J5 on graft-versus-host disease induced by minor histocompatibility antigens in mice. Transplantation (Baltimore). 44:249.
55. + and CD3" lymphocytes. Immunol. Rev. 97:51.
56. Charley, M.R., A. Mikhael, M. Bennett, J.N. Gilliam, and R.D. Sontheimer. 1983. Prevention of lethal, minor-determinate, graft-vs-disease by the in vivo administration of anti-asialo GM1. J. Immunol. 131:2101.
57. Ghayur, T., T.A. Seemayer, P.A.L. Kongshavn, J.G. Gartner, and W.S. Lapp. 1987. Graft-versus-host reactions in the beige mouse: An investigation of the role of natural killer cells in the pathogenesis of GVH disease. Transplantation (Baltimore). 44:261.
58. + cells of donor origin. Transplantation (Baltimore). 45:586.
59. + graft-versus-host effector cells of donor origin. Scand. J. Immunol. 34:497.
60. Vlassara, H., M. Brownlee, K.R. Manogue, C.A. Dinarello, and A. Pasagian. 1988. Cachectin/TNF and IL-1 induced by glucose-modified proteins: Role in normal tissue remodeling. Science (Wash. DC). 240:1546.
61. Wall, D.A., S.D. Hamburg, D.S. Reynolds, S.J. Burakoff, A.K. Abbas, and J.L.M. Ferrara. 1988. Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression. J. Immunol. 140:2970.
62. Havell, E.A. 1989. Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol. 143:2894.
63. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohn, A. Möller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumor necrosis factor in vitro. Nature (Lond.). 323:816.
64. Djeu, J.Y., D. Blanchard, D. Halkias, and H. Friedman. 1986. Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: Activation by IFN-y and tumor necrosis factor. J. Immunol. 137:2980.